QSS
BMY icon

Quantitative Systematic Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Quantitative Systematic Strategies’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,528
Closed -$1.42M – 486
2021
Q1 		$1.42M Buy
+22,528
New +$1.4M 0.22% 143
2020
Q4 		– Sell
-49,743
Closed -$3M – 624
2020
Q3 		$3M Sell
49,743
-44,193
-47% -$2.66M 0.52% 43
2020
Q2 		$5.52M Buy
93,936
+59,358
+172% +$3.55M 1.09% 2
2020
Q1 		$1.93M Sell
34,578
-21,509
-38% -$1.31M 1.58% 4
2019
Q4 		$3.6M Buy
56,087
+45,309
+420% +$2.59M 0.53% 51
2019
Q3 		$547K Sell
10,778
-32,841
-75% -$1.54M 0.13% 215
2019
Q2 		$1.98M Buy
43,619
+23,844
+121% +$1.11M 0.37% 89
2019
Q1 		$943K Sell
19,775
-17,212
-47% -$857K 0.23% 141
2018
Q4 		$1.92M Buy
36,987
+13,843
+60% +$744K 0.43% 42
2018
Q3 		$1.44M Sell
23,144
-4,806
-17% -$285K 0.27% 119
2018
Q2 		$1.55M Sell
27,950
-3,951
-12% -$213K 0.28% 102
2018
Q1 		$2.02M Sell
31,901
-5,504
-15% -$354K 0.43% 44
2017
Q4 		$2.29M Sell
37,405
-1,731
-4% -$108K 0.58% 18
2017
Q3 		$2.5M Sell
39,136
-6,315
-14% -$369K 0.66% 15
2017
Q2 		$2.54M Buy
45,451
+13,323
+41% +$725K 0.65% 25
2017
Q1 		$1.75M Buy
32,128
+26,260
+448% +$1.44M 0.49% 91
2016
Q4 		$346K Buy
+5,868
New +$321K 0.14% 234
2016
Q3 		– Sell
-22,113
Closed -$1.61M – 387
2016
Q2 		$1.61M Buy
22,113
+8,559
+63% +$605K 0.75% 8
2016
Q1 		$860K Buy
13,554
+5,824
+75% +$367K 0.33% 106
2015
Q4 		$537K Sell
7,730
-29,332
-79% -$1.94M 0.15% 173
2015
Q3 		$2.19M Buy
37,062
+28,580
+337% +$1.81M 1.08% 2
2015
Q2 		$560K Sell
8,482
-5,872
-41% -$387K 0.12% 297
2015
Q1 		$944K Sell
14,354
-8,466
-37% -$530K 0.26% 133
2014
Q4 		$1.35M Buy
+22,820
New +$1.29M 0.54% 54
2014
Q2 		– Sell
-7,694
Closed -$399K – 254
2014
Q1 		$399K Sell
7,694
-25,123
-77% -$1.34M 0.33% 133
2013
Q4 		$1.75M Buy
+32,817
New +$1.67M 1.42% 6

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Quantitative Systematic Strategies's BMY Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 22,528 shares — an estimated $1.42M sold.

Quantitative Systematic Strategies first reported a position in BMY in Q4 2013 and held it in 26 quarters. The position peaked at $5.52M in Q2 2020. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 22,528 Bristol-Myers Squibb shares in Q2 2021, an estimated $1.42M.
  • Quantitative Systematic Strategies first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 26 quarters.
  • Quantitative Systematic Strategies's Bristol-Myers Squibb position peaked at $5.52M in Q2 2020.
  • 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.